News

Hughes Hubbard Strengthens Litigation Team with New Acquisition

Hughes Hubbard Strengthens Litigation Team with New Acquisition

Hughes Hubbard & Reed Expands with the Addition of Schulman Bhattacharya

NEW YORK and WASHINGTON — Hughes Hubbard & Reed LLP has successfully completed the acquisition of Schulman Bhattacharya LLC, a notable litigation and arbitration boutique based in Washington, D.C. This strategic move aims to enhance Hughes Hubbard's ability to serve clients engaged in complex disputes.

The integration of Schulman Bhattacharya into Hughes Hubbard signifies a commitment to excellence in legal service. This is especially vital for clients navigating high-stakes cases, especially in the heart of U.S. litigation activity like D.C.

Neil J. Oxford, the chair of Hughes Hubbard, expressed excitement about welcoming the exceptional team from Schulman Bhattacharya. He emphasized the benefits of this acquisition, stating, "This acquisition continues the positive momentum as we strategically invest in firm growth, enhancing our litigation and arbitration practices as well as complementing our finance team."

The attorneys from Schulman Bhattacharya possess a robust portfolio, representing clients from various sectors such as real estate, finance, and pharmaceuticals. Their expertise spans across complex commercial litigation, both international and domestic arbitration, internal investigations, and corporate counseling. They have consistently represented clients in federal and state courts throughout the country as well as at various international arbitration forums.

Joining Hughes Hubbard from Schulman Bhattacharya are esteemed partners Jeremy W. Schulman, Koushik Bhattacharya, and Jeffrey S. Gavenman, along with two counsel and two associates. Jeremy Schulman will take the lead role in the D.C. litigation practice.

Schulman noted, "Hughes Hubbard's commitment to service and a culture promoting independence and excellence aligns perfectly with our values. I am looking forward to joining this remarkable team."

Gavenman, equally enthusiastic, expressed eagerness to collaborate with Hughes Hubbard’s talented litigators across various practice areas. He stated that they will continue to deliver exceptional results for their clients.

The accomplishments of Schulman Bhattacharya lawyers showcase their capability to deliver favorable outcomes. Notably, one case saw them act as national litigation counsel for a major pharmaceutical company, achieving an $18 million jury verdict, a permanent injunction, and successful appeals that affirmed these achievements. This further solidified their reputation in the industry.

Another significant victory was for a private equity firm involved in a $480 million petroleum company sale. The Schulman team successfully won summary judgment on all counts, while also obtaining a financial recovery of over $65 million, including legal fees.

Schulman Bhattacharya lawyers also represented several minority partners in real estate-related disputes valued over $500 million, securing multiple confidential settlements, some even in the midst of trials.

Furthermore, Schulman served as national litigation counsel for a real estate-backed lender, achieving impressive results by winning summary judgment in over 20 cases, securing judgments, and settlements exceeding $30 million.

This merger with Schulman Bhattacharya comes on the heels of previous strategic additions, which included project finance partners in both Washington and New York, aiming to bolster their capabilities in various domains.

Hughes Hubbard has garnered recognition, including being a finalist for the Litigation Department of the Year by New York Law Journal and holds top rankings by Chambers and Legal 500 in multiple areas such as Banking & Finance, Commercial Litigation, International Arbitration, Bankruptcy/Restructuring, White-Collar Crime & Government Investigations, and more. This acquisition not only enhances their reputational standing but also positions them for future growth and success.

Frequently Asked Questions

What is the significance of Hughes Hubbard's acquisition?

The acquisition of Schulman Bhattacharya enhances Hughes Hubbard's litigation and arbitration capabilities, allowing for improved client service and expert legal representation in complex disputes.

Who are the key partners joining Hughes Hubbard from Schulman Bhattacharya?

Jeremy W. Schulman, Koushik Bhattacharya, and Jeffrey S. Gavenman are among the key partners joining Hughes Hubbard, bringing considerable experience to the firm's litigation practice.

What industries do Schulman Bhattacharya's lawyers represent?

The attorneys at Schulman Bhattacharya represent clients across diverse sectors, including real estate, finance, healthcare, and more, focusing on complex commercial litigation and arbitration.

What recent accomplishments have Schulman Bhattacharya lawyers achieved?

They have secured significant verdicts and settlements, including an $18 million jury verdict for a pharmaceutical client and over $65 million in a private equity litigation victory.

How does this acquisition align with Hughes Hubbard's growth strategy?

This acquisition complements Hughes Hubbard's strategic investments, further strengthening their litigation and finance practices and expanding their reach in the competitive legal market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celebree School Champions Screen-Free Imagination Era

Updated Category News Views 3

Nostalgia often carries us back to simpler times, whether it's building blanket forts or putting on living room plays. Today, these memories are stirring up a movement, and Celebree School is at the heart of the whirlwind. They're rolling out a campaign aptly titled "Boredom Is Where Imagination Begins," aimed at reintroducing children to creativity beyond screens and...

Continue Reading
Omnis Energy's Control Clash Hits Court Showdown

Updated Category News Views 1

Sparks Fly Over Pleasants Power Just when you think you’ve seen every trick in the playbook, along comes another tussle worth its weight in megawatts. Omnis Energy, under its formal name Omnis Pleasants, finds itself in a fiery battle with creditors as the Chapter 11 proceedings heat up over the Pleasants Power Station. With six objections filed ahead of a crucial court...

Continue Reading
ADA Audit Reveals Gaps in Event Management at 2026 Session

Updated Category News Views 1

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Continue Reading
Medtronic's Q1 2027 Surge Signals Promising Future

Updated Category News Views 2

Medtronic's Impressive Q1 2027: A Closer Look It's not every day you see a healthcare titan like Medtronic (NYSE: MDT) flex some serious muscle on the financial front. As the first quarter of fiscal year 2027 wrapped up, Medtronic delivered a knockout with a reported 13.7% increase in revenue, totaling a hefty $9.8 billion. This wasn't just luck—this was strategic...

Continue Reading
Nauticus Robotics' ROV Activity Boosts Q3 Performance

Updated Category News Views 0

Nauticus Robotics Hits New Stride with ROV Deployments Some days, you're paddling like hell to stay afloat in this market. But for Nauticus Robotics, marking progress amidst turbulent waters, their recent announcement feels like catching a favorable current. Both of Nauticus’ Comanche ROV systems have been deployed for commercial projects, enhancing their third quarter...

Continue Reading
Panoplai's Rocket Ride: No. 320 on Inc. 5000

Updated Category News Views 2

Panoplai's Meteoric Rise in the AI Landscape There's nothing quite like seeing a company break through the noise with numbers that can make even the most jaded investor sit up straight. Panoplai, an AI-powered insights platform, has done just that, snagging a spot at No. 320 on the 2026 Inc. 5000 list of America's fastest-growing private companies with an eye-popping...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 4

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
CIC Services Unleashes PortfolioVantage for Property Owners

Updated Category News Views 1

Eyeing Profit in Tenant Liability Insurance CIC Services has cooked up something intriguing for property owners: a shot at fatter profits through their PortfolioVantage program. Launching now, this tenant legal liability strategy promises more than just basic tenant coverage—it's a potential financial boon for savvy landlords willing to dive in. The Gist of...

Continue Reading
Steve McCurry's Mastery Captured in 'Adagio' Exhibition

Updated Category News Views 3

The Reverie of Real Imagery It might be time to give New York a spot on your calendar. Adagio, the latest exhibition at Leica Gallery, reveals the enduring magic of Steve McCurry's lens. Running from September 10th to October 18th, 2026, this event does more than showcase photos—it crafts an experience of human connection. A Dance with History This isn’t just a walk...

Continue Reading
MiniMed's Fiery Start to FY27: Growth Sparks Excitement

Updated Category News Views 3

MiniMed's Bold Initial Move for Fiscal Year 2027 Ah, MiniMed's come out swinging to kick off FY27, and it’s about time somebody did something right. With net sales clocking in at $843 million, marking a 17% spike as reported and 16% organic growth, you'd think we’d be talking about a tech startup, not a diabetes tech stalwart. These folks have been around for ages,...

Continue Reading

Top 5 Most Recently Viewed Articles

Altus Group Reports Strong Voting Participation at Recent AGM

Updated Category News Views 176

Altus Group Voting Results from the Annual General Meeting Altus Group Limited ("Altus Group" or "the Company") (TSX: AIF), recognized as a leader in commercial real estate intelligence, recently announced the final voting results from its annual general meeting of shareholders, held virtually to enhance participation. The meeting saw an impressive turnout, with a total...

Continue Reading
Revolutionizing Logistics: The Human-Centric Approach of Orchestro.ai

Updated Category News Views 175

Transforming the Future of Logistics with Compassion The partnership between Orchestro.ai and The Supply Chain Project (TSCP) is pioneering a new approach to logistics that prioritizes compassion and humanity. This innovative initiative, dubbed Angelic Intelligence Matching, integrates a virtue-based artificial intelligence framework into the supply chain, ensuring that...

Continue Reading
Analyzing Zevra Therapeutics' Earnings and Future Performance

Updated Category News Views 101

Insights into Zevra Therapeutics' Earnings Report Zevra Therapeutics (NASDAQ: ZVRA) is set to unveil its quarterly earnings report soon, generating heightened interest among investors looking for updates on its financial health. Analysts predict an earnings per share (EPS) of $1.40, establishing high expectations for the upcoming announcement. Expectations Surrounding the...

Continue Reading
Walmart's Bullish Trajectory: Is Now the Right Time to Invest?

Updated Category News Views 148

Walmart's stock shot up over 51% year-to-date back in 2024, making it a standout performer against both its sector and the broader market. You had traders buzzing about Citi’s bullish upgrade, lifting their price target from $75 to $98. That kinda confidence ain't just noise; it comes from solid market share gains in groceries and a push into high-margin areas like...

Continue Reading
Texas Sees Surge in International Homebuying Activity

Updated Category News Views 126

Texas Experiences Growth in International Home Purchases Total transactions, median price, and dollar volume in home purchases have shown a significant increase in Texas. According to recent reports, the number of residential properties sold to international buyers soared nearly 9% over the previous year, reaching impressive figures. Remarkable Increase in Cross-Border...

Continue Reading